Location History:
- Cambridge, MA (US) (1994 - 1996)
- Indianapolis, IN (US) (1997 - 2004)
Company Filing History:
Years Active: 1994-2004
Title: Spotlight on Inventor Deborah A Evrard
Introduction:
Deborah A Evrard, a notable inventor based in Cambridge, MA, has made significant contributions to the field of medicine with 11 patents to her credit. Her latest patents focus on selective β3 adrenergic agonists for the treatment of Type II diabetes and obesity.
Latest Patents:
Evrard's recent patents center around the development of selective β3 adrenergic agonists, targeting the treatment of Type II diabetes and obesity. These compounds, outlined in Formula I, offer innovative methods for managing these conditions, demonstrating her commitment to advancing healthcare solutions.
Career Highlights:
Currently affiliated with Eli Lilly and Company, Evrard brings her expertise and dedication to the pharmaceutical industry. Her role in developing novel treatments underscores her passion for improving patient outcomes and addressing unmet medical needs.
Collaborations:
Throughout her career, Evrard has collaborated with esteemed professionals in the field, including coworkers James E Audia and James Joseph Droste. These partnerships have fostered a collaborative environment where innovative ideas thrive, leading to groundbreaking advancements in medicine.
Conclusion:
Inventor Deborah A Evrard's pioneering work in the realm of selective β3 adrenergic agonists highlights her commitment to innovation and improving healthcare. Her patents stand as a testament to her dedication to advancing treatment options for Type II diabetes and obesity, shaping the future of medicine for the better.